Luna, Brian http://orcid.org/0000-0001-6718-4551
Trebosc, Vincent
Lee, Bosul
Bakowski, Malina
Ulhaq, Amber
Yan, Jun http://orcid.org/0000-0001-7509-2067
Lu, Peggy
Cheng, Jiaqi
Nielsen, Travis http://orcid.org/0000-0003-3366-7912
Lim, Juhyeon
Ketphan, Warisa
Eoh, Hyungjin http://orcid.org/0000-0001-8774-6400
McNamara, Case
Skandalis, Nicholas http://orcid.org/0000-0002-4236-8909
She, Rosemary
Kemmer, Christian
Lociuro, Sergio
Dale, Glenn E.
Spellberg, Brad http://orcid.org/0000-0002-3632-1709
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI139052, R01AI130060, R01AI117211)
Federal Drug Administration (FDA)
Bill and Melinda Gates Foundation (OPP1107194)
Article History
Received: 4 March 2020
Accepted: 10 May 2020
First Online: 8 June 2020
Change Date: 17 June 2020
Change Type: Update
Change Details: In the version of this Article originally published, the authors’ first names were formatted as initials. This has now been corrected and the authors’ full names are displayed.
Competing interests
: B.L., B.S. and T.N. own equity in ExBaq. The University of Southern California has a financial interest in ExBaq. G.E.D., V.T., C.K. and S.L. own equity in BioVersys.